Award Presented by Greater Philadelphia Alliance for Capital and Technologies at Organization's Annual Event - from MarketWatch

Business Wire press release

May 7, 2012, 9:46 a.m. EDT

Octagon Research Solutions, Inc. Named Emerging Life Sciences Company of the Year

WAYNE, Pa., May 07, 2012 (BUSINESS WIRE) -- Octagon Research Solutions, Inc. (Octagon), the leader in transforming clinical R&D through an integrated suite of regulatory, clinical, process and technology solutions, announced today that it has been named Emerging Life Sciences Company of the Year by the Greater Philadelphia Alliance for Capital and Technologies (PACT) at its annual Enterprise Awards Gala, held on May 3, 2012. The award honors growing companies in the region's life sciences industry that demonstrate clear, measurable growth and success during 2011.

"We are honored to receive this recognized award, and I am equally proud of the Octagon team's unparalleled focus on our customers as well as their proven expertise in bringing new efficiencies to the clinical and regulatory information landscape," said James C. Walker, chairman and chief executive officer of Octagon Research Solutions, Inc. "By adding more than 100 new employees globally and expanding our operations in three countries, Octagon is well positioned to be the market leader in streamlining clinical R&D processes through our integrated suite of technology solutions, outsourcing options and consulting services." Mr. Walker was also named Technology CEO of the Year by PACT in 2011.

Octagon has been an integral part of the greater Philadelphia life sciences community since 1999, and has made a significant contribution to the regional economy by creating more than 300 high-wage jobs at its global headquarters in Wayne, Pennsylvania. By taking a holistic view of the clinical R&D process, Octagon has been able to develop a suite of regulatory, clinical, consulting and technology solutions that reduce rework and positively impact the race to market. The company's growth has been guided by the strategic planning by Octagon's executive leadership team and has been driven by the company's clinical data and regulatory subject matter experts.

Octagon works with 350 client companies of all sizes on three continents, including forty of the top fifty global pharmaceutical companies. Octagon's subject matter experts are frequent industry speakers, and are contributors to various key associations and standards organizations, including the Clinical Data Interchange Standards Consortium (CDISC), the Drug Information Association (DIA) and The Organisation for Professionals in Regulatory Affairs (TOPRA).

more... http://www.marketwatch.com/story/octagon-research-solutions-inc-named-emerging-life-sciences-company-of-the-year-2012-05-07